Onconova Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, ONTX, Onconova Therapeutics Inc, priceseries

Onconova Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
1.55
Close
1.50
High
1.55
Low
1.49
Previous Close
1.54
Daily Price Gain
-0.04
YTD High
2.84
YTD High Date
Jan 4, 2022
YTD Low
1.38
YTD Low Date
Feb 24, 2022
YTD Price Change
-1.32
YTD Gain
-46.81%
52 Week High
19.65
52 Week High Date
Mar 17, 2021
52 Week Low
1.38
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-13.42
52 Week Gain
-89.95%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 9. 2017
542.25
Jan 18. 2017
595.62
6 Trading Days
9.84%
Link
LONG
Oct 6. 2017
393.75
Oct 20. 2017
517.98
10 Trading Days
31.55%
Link
LONG
Jan 3. 2018
342.00
Jan 18. 2018
368.54
10 Trading Days
7.76%
Link
LONG
Jun 5. 2018
94.95
Jun 13. 2018
117.51
6 Trading Days
23.76%
Link
LONG
Sep 10. 2018
99.00
Sep 19. 2018
104.17
7 Trading Days
5.23%
Link
LONG
Jan 30. 2019
36.60
Feb 11. 2019
46.56
8 Trading Days
27.23%
Link
LONG
Mar 13. 2019
53.85
Mar 26. 2019
58.75
9 Trading Days
9.09%
Link
LONG
Dec 26. 2019
4.70
Dec 31. 2019
5.32
3 Trading Days
13.27%
Link
LONG
Feb 5. 2020
6.20
Feb 11. 2020
6.56
4 Trading Days
5.88%
Link
LONG
Mar 24. 2020
5.51
Mar 25. 2020
5.90
1 Trading Days
7.17%
Link
LONG
May 7. 2020
4.80
May 26. 2020
5.49
12 Trading Days
14.40%
Link
LONG
May 27. 2020
5.85
Jun 25. 2020
8.20
21 Trading Days
40.10%
Link
LONG
Jul 15. 2020
8.66
Jul 29. 2020
14.89
10 Trading Days
71.90%
Link
LONG
Nov 30. 2020
4.35
Jan 22. 2021
10.77
36 Trading Days
147.62%
Link
LONG
Feb 3. 2021
12.75
Feb 23. 2021
19.35
13 Trading Days
51.80%
Link
LONG
May 17. 2021
9.30
May 21. 2021
10.46
4 Trading Days
12.50%
Link
Company Information
Stock Symbol
ONTX
Exchange
NasdaqCM
Company URL
http://www.onconova.com
Company Phone
267-759-3681
CEO
Ramesh Kumar
Headquarters
Pennsylvania
Business Address
375 PHEASANT RUN, NEWTOWN, PA 18940
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001130598
About

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing novel small molecule drug candidates to treat cancer. It uses a proprietary chemistry platform has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are essential in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.

Description

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. The company's clinical-stage product candidates include Rigosertib IV, which is in Phase III clinical trials for patients with higher risk myelodysplastic syndromes (MDS); Rigosertib oral in combination with azacitidine that is in Phase II clinical trials for patients with MDS and acute myelogenous leukemia; and Rigosertib oral, which is in Phase II clinical trials for patients with lower risk MDS. Its clinical-stage product candidates also comprise Briciclib, which is in Phase I multisite dose-escalation trial for patients with advanced solid tumors; and Recilisib that has completed four Phase I clinical trials for patients with acute radiation syndromes. In addition, the company has various product candidates that target kinases, cellular metabolism, or cell division in preclinical development. It has a development and license agreement with Baxter Healthcare SA; and a license agreement with SymBio Pharmaceuticals Limited. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading